Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HIMS Hims & Hers Health	$36.75 -0.1%	$28.61	$13.74 ▼ $70.43	$8.52B	2.35	18.22 million shs	16.44 million shs
NVO Novo Nordisk A/S	$50.39 -0.1%	$44.70	$35.12 ▼ $71.79	$225.17B	0.77	12.52 million shs	12.06 million shs
PFE Pfizer	$24.29 -0.1%	$25.63	$23.11 ▼ $28.75	$138.61B	0.35	48.49 million shs	52.80 million shs
TDOC Teladoc Health	$9.19 -0.1%	$7.19	$4.40 ▼ $9.77	$1.66B	2.1	4.18 million shs	4.28 million shs
WW WW International	$16.31	$14.37	$8.36 ▼ $46.95	$163.08M	1.3	321,913 shs	73,871 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HIMS Hims & Hers Health	0.00%	+8.52%	+33.68%	+91.84%	-22.55%
NVO Novo Nordisk A/S	0.00%	+4.95%	+19.81%	+36.47%	-27.82%
PFE Pfizer	0.00%	+0.07%	-4.23%	-14.36%	-4.06%
TDOC Teladoc Health	0.00%	+9.89%	+29.82%	+73.89%	+10.06%
WW WW International	0.00%	+2.00%	+1.12%	+14.30%	-29.74%

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
HIMS Hims & Hers Health	$36.75 -0.1%	$28.61	$13.74 ▼ $70.43	$8.52B	2.35	18.22 million shs	16.44 million shs
NVO Novo Nordisk A/S	$50.39 -0.1%	$44.70	$35.12 ▼ $71.79	$225.17B	0.77	12.52 million shs	12.06 million shs
PFE Pfizer	$24.29 -0.1%	$25.63	$23.11 ▼ $28.75	$138.61B	0.35	48.49 million shs	52.80 million shs
TDOC Teladoc Health	$9.19 -0.1%	$7.19	$4.40 ▼ $9.77	$1.66B	2.1	4.18 million shs	4.28 million shs
WW WW International	$16.31	$14.37	$8.36 ▼ $46.95	$163.08M	1.3	321,913 shs	73,871 shs

7 Energy Stocks to Buy and Hold Forever

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
HIMS Hims & Hers Health	0.00%	+8.52%	+33.68%	+91.84%	-22.55%
NVO Novo Nordisk A/S	0.00%	+4.95%	+19.81%	+36.47%	-27.82%
PFE Pfizer	0.00%	+0.07%	-4.23%	-14.36%	-4.06%
TDOC Teladoc Health	0.00%	+9.89%	+29.82%	+73.89%	+10.06%
WW WW International	0.00%	+2.00%	+1.12%	+14.30%	-29.74%

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
HIMS Hims & Hers Health	2.13	Hold	$30.63	-16.64% Downside
NVO Novo Nordisk A/S	2.17	Hold	$65.56	30.12% Upside
PFE Pfizer	2.25	Hold	$28.82	18.66% Upside
TDOC Teladoc Health	2.24	Hold	$7.43	-19.11% Downside
WW WW International	1.75	Reduce	N/A	N/A

Current Analyst Ratings Breakdown

Latest NVO, PFE, TDOC, HIMS, and WW Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/1/2026	WW WW International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Sell (D) ➝ Sell (D-)
7/1/2026	HIMS Hims & Hers Health	Canaccord Genuity Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Buy	$32.00 ➝ $40.00
7/1/2026	HIMS Hims & Hers Health	Bank of America Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Neutral	$25.00 ➝ $36.00
6/23/2026	PFE Pfizer	BMO Capital Markets Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Outperform
6/19/2026	NVO Novo Nordisk A/S	Nordea Equity Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Hold ➝ Buy
6/17/2026	WW WW International	Weiss Ratings Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Sell (D)
6/17/2026	HIMS Hims & Hers Health	Barclays Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Boost Price Target	Overweight	$29.00 ➝ $39.00
6/9/2026	PFE Pfizer	Royal Bank Of Canada Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Upgrade	Underperform ➝ Sector Perform	$25.00
6/8/2026	HIMS Hims & Hers Health	Zacks Research Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Downgrade	Hold ➝ Strong Sell
6/1/2026	PFE Pfizer	Cantor Fitzgerald Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral
5/27/2026	PFE Pfizer	UBS Group Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating	Reiterated Rating	Neutral	$27.00

(Data available from 7/4/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
HIMS Hims & Hers Health	$2.35B	3.62	$0.84 per share	43.97	$2.38 per share	15.44
NVO Novo Nordisk A/S	$46.80B	4.81	$4.68 per share	10.76	$6.58 per share	7.66
PFE Pfizer	$62.58B	2.21	$4.39 per share	5.53	$15.26 per share	1.59
TDOC Teladoc Health	$2.53B	0.66	$1.80 per share	5.11	$7.81 per share	1.18
WW WW International	$710.64M	0.23	$13.82 per share	1.18	($9.62) per share	-1.70

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
HIMS Hims & Hers Health	$128.37M	-$0.09	N/A	73.50	52.60	-0.56%	6.10%	1.52%	8/10/2026 (Estimated)
NVO Novo Nordisk A/S	$15.51B	$4.26	11.83	15.41	4.60	37.23%	63.31%	22.19%	8/5/2026 (Estimated)
PFE Pfizer	$7.77B	$1.31	18.54	8.49	N/A	11.83%	19.44%	8.41%	8/4/2026 (Estimated)
TDOC Teladoc Health	-$200.32M	-$0.97	N/A	N/A	N/A	-6.81%	-11.45%	-5.54%	7/29/2026 (Estimated)
WW WW International	-$112.25M	-$6.22	N/A	N/A	N/A	-56.84%	N/A	-0.32%	7/30/2026 (Estimated)

Latest NVO, PFE, TDOC, HIMS, and WW Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
7/30/2026	Q2 2026	WW WW International	$0.48	N/A	N/A	N/A	$159.13 million	N/A
7/29/2026	Q2 2026	TDOC Teladoc Health	-$0.24	N/A	N/A	N/A	$614.80 million	N/A
5/11/2026	Q1 2026	HIMS Hims & Hers Health	$0.04	-$0.40	-$0.44	-$0.40	$616.84 million	$608.10 million
5/7/2026	Q1 2026	WW WW International	-$0.8467	-$5.20	-$4.3533	-$5.20	$149.80 million	$168.26 million
5/6/2026	Q1 2026	NVO Novo Nordisk A/S	$0.87	$1.04	+$0.17	$1.69	$10.86 billion	$10.85 billion
5/5/2026	Q1 2026	PFE Pfizer	$0.7220	$0.75	+$0.0280	$0.47	$13.84 billion	$14.45 billion
4/29/2026	Q1 2026	TDOC Teladoc Health	-$0.3454	-$0.36	-$0.0147	-$0.36	$611.04 million	$613.85 million

Compare Dividends

Company	Annual Payout	Dividend Yield	5-Year Annualized Dividend Growth	Payout Ratio	Years of Consecutive Growth
HIMS Hims & Hers Health	N/A	N/A	N/A	N/A	N/A
NVO Novo Nordisk A/S	$1.75	3.47%	+21.74%	41.08%	N/A
PFE Pfizer	$1.72	7.08%	-13.20%	131.30%	16 Years
TDOC Teladoc Health	N/A	N/A	N/A	N/A	N/A
WW WW International	N/A	N/A	N/A	N/A	N/A

Latest NVO, PFE, TDOC, HIMS, and WW Dividends

Announcement	Company	Period	Amount	Yield	Ex-Dividend Date	Record Date	Payable Date
6/24/2026	PFE Pfizer	quarterly	$0.43	7.15%	7/24/2026	7/24/2026	9/1/2026
4/22/2026	PFE Pfizer	quarterly	$0.43	6.71%	5/8/2026	5/8/2026	6/12/2026

(Data available from 1/1/2013 forward)

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
HIMS Hims & Hers Health	2.18	1.69	1.56
NVO Novo Nordisk A/S	0.59	0.79	0.56
PFE Pfizer	0.67	1.25	0.94
TDOC Teladoc Health	0.75	2.80	2.72
WW WW International	N/A	0.53	0.53

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
HIMS Hims & Hers Health	63.52%
NVO Novo Nordisk A/S	11.54%
PFE Pfizer	68.36%
TDOC Teladoc Health	76.82%
WW WW International	86.18%

Insider Ownership

Company	Insider Ownership
HIMS Hims & Hers Health	11.76%
NVO Novo Nordisk A/S	0.07%
PFE Pfizer	0.62%
TDOC Teladoc Health	0.70%
WW WW International	0.39%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
HIMS Hims & Hers Health	2,442	231.46 million	204.24 million	Optionable
NVO Novo Nordisk A/S	69,505	4.47 billion	4.46 billion	Optionable
PFE Pfizer	75,000	5.70 billion	5.66 billion	Optionable
TDOC Teladoc Health	5,600	180.51 million	179.25 million	Optionable
WW WW International	7,700	10.00 million	73.38 million	Optionable

NVO, PFE, TDOC, HIMS, and WW Headlines

Recent News About These Companies

WW International Inc.: Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program

June 30, 2026 | finanznachrichten.de

Weight Watchers Med+ Establishes Access to GLP-1s Through Medicare GLP-1 Bridge Program

June 30, 2026 | globenewswire.com

WW International Inc (NASDAQ: WW) - Share Price and Research

June 27, 2026 | intelligentinvestor.com.auI

WW International (NASDAQ:WW) Shares Cross Above Two Hundred Day Moving Average - Should You Sell?

June 23, 2026 | americanbankingnews.com

Weight Watchers to Support the American Heart Association's Healthy Living BEYOND Weight Study

June 22, 2026 | globenewswire.com

WW International Inc.: Weight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK

June 16, 2026 | finanznachrichten.de

Weight Watchers and CheqUp Expand Partnership To Deliver Holistic Support for Weight Health in the UK

June 16, 2026 | globenewswire.com

WW International: New Initiatives Not Enough

June 12, 2026 | seekingalpha.com

Weight Watchers Broadens GLP-1 Reach As Eli Lilly Pursues New Kidney Disease Therapies

June 4, 2026 | benzinga.com

Weight Watchers to Increase Access to Comprehensive Weight Loss Options for Patients Nationwide through LillyDirect

June 4, 2026 | globenewswire.com

WW International Earnings Call Highlights Clinical Pivot

June 1, 2026 | tipranks.com

Insider Buying: WW International (NASDAQ:WW) CFO Acquires 1,500 Shares of Stock

May 28, 2026 | insidertrades.com

Top WW International Insiders Quietly Load Up on Shares

May 21, 2026 | tipranks.com

Galloway Capital Discloses 8.42% Stake in WW International

May 13, 2026 | news.bloomberglaw.comN

WW International (WW) price target decreased by 23.42% to 28.90

May 13, 2026 | msn.com

WW International gains as Galloway Capital discloses 8.42% stake

May 13, 2026 | seekingalpha.com

Galloway Capital Partners Announces Investment in WW International and Believes Shares Are Worth Multiples of Current Price

May 13, 2026 | businesswire.com

WW International, Inc. (WW) Q1 2026 Earnings Call Transcript

May 11, 2026 | seekingalpha.com

WW International Logs Lower Sales

May 7, 2026 | wsj.com

Weight Watchers Announces First Quarter 2026 Results

May 7, 2026 | globenewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

NVO, PFE, TDOC, HIMS, and WW Company Descriptions

Hims & Hers Health NYSE:HIMS

$36.75 -0.05 (-0.14%)

Closing price 07/2/2026 03:59 PM Eastern

Extended Trading

$37.00 +0.25 (+0.69%)

As of 07/2/2026 08:00 PM Eastern

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Novo Nordisk A/S NYSE:NVO

$50.39 -0.04 (-0.09%)

Closing price 07/2/2026 03:59 PM Eastern

Extended Trading

$50.31 -0.08 (-0.15%)

As of 07/2/2026 07:59 PM Eastern

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with Aspen Pharmaceuticals to produce insulin products; and with Korro Bio, Inc. for the discovery and development of new genetic medicines to treat cardiometabolic diseases. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.

Pfizer NYSE:PFE

$24.29 -0.03 (-0.12%)

Closing price 07/2/2026 03:59 PM Eastern

Extended Trading

$24.34 +0.05 (+0.22%)

As of 07/2/2026 07:59 PM Eastern

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States, Europe, and internationally. The company offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic, migraine, and women's health under the Eliquis, Nurtec ODT/Vydura, Zavzpret, and the Premarin family brands; infectious diseases with unmet medical needs under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and COVID-19 prevention and treatment, and potential future mRNA and antiviral products under the Comirnaty and Paxlovid brands. It also provides medicines and vaccines in various therapeutic areas, such as biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Litfulo, Velsipity, and Cibinqo brands; amyloidosis, hemophilia, endocrine diseases, and sickle cell disease under the Vyndaqel family, Oxbryta, BeneFIX, Somavert, Ngenla, and Genotropin brands; sterile injectable and anti-infective medicines under the Sulperazon, Medrol, Zavicefta, Zithromax, and Panzyga brands; and biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Inlyta, Bosulif, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio, Tivdak, Lorbrena, and Braftovi brands. In addition, the company involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, retail pharmacies, and integrated delivery systems. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Teladoc Health NYSE:TDOC

$9.19 -0.01 (-0.11%)

Closing price 07/2/2026 03:59 PM Eastern

Extended Trading

$9.06 -0.13 (-1.36%)

As of 07/2/2026 07:36 PM Eastern

Teladoc Health, Inc. provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

WW International NASDAQ:WW

$16.31 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$16.36 +0.05 (+0.31%)

As of 07/2/2026 04:39 PM Eastern

WW International, Inc. provides weight management products and services worldwide. It offers a range of nutritional, activity, behavioral, and lifestyle tools and approaches products and services. The company also provides various digital subscription products to wellness and weight management business, which provide interactive and personalized resources that allow users to follow its weight management program through its app and web-based platform; and allows members to inspire and support each other by sharing their experiences with other people on weight health journeys. In addition, it licenses its trademarks and other intellectual property in food, beverages, and other relevant consumer products and services, as well as provides publishing services. The company was formerly known as Weight Watchers International, Inc. and changed its name to WW International, Inc. in September 2019. WW International, Inc. was founded in 1961 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time

Compare Price & Volume

Compare Price Performance

Compare Price & Volume

Compare Price Performance

Compare Analyst Forecasts

Current Analyst Ratings Breakdown

Latest NVO, PFE, TDOC, HIMS, and WW Analyst Ratings

Compare Sales & Book Value

Compare Profitability & Earnings

Latest NVO, PFE, TDOC, HIMS, and WW Earnings

Compare Dividends

Latest NVO, PFE, TDOC, HIMS, and WW Dividends

Compare Debt

Compare Ownership

Institutional Ownership

Insider Ownership

Compare Miscellaneous Stats

NVO, PFE, TDOC, HIMS, and WW Headlines

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

NVO, PFE, TDOC, HIMS, and WW Company Descriptions

Hims & Hers Health NYSE:HIMS

Novo Nordisk A/S NYSE:NVO

Pfizer NYSE:PFE

Teladoc Health NYSE:TDOC

WW International NASDAQ:WW

More Stock Comparisions from MarketBeat

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools